Category:
Prophylactic Biological Products
This fixed-dose combination tablet integrates Diclofenac potassium (50mg), Chlorzoxazone (250mg), and Paracetamol (325mg) for synergistic analgesic and muscle relaxant effects. The manufacturing process employs direct compression or wet granulation to ensure bioequivalence.
Contraindicated in patients with active peptic ulcers, severe hepatic impairment, or hypersensitivity to NSAIDs. Store below 25°C in a dry place away from light to maintain chemical stability.